ALEC
AlectorDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade D from latest DB weights. Momentum 16.3 / Value 58.8
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +17.6.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
16
Value
59
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $3.10
Why
Momentum16 · Δ7d -
Value59 · Δ7d +17.6
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
16
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
59
60% active weight
Current posture
7d trendImproving
Δ7d
+17.6
Δ21d
+17.7
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 16.3 / Value 58.8
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$166.54M
Beta
0.64
Shares Out
111.03M
P/E (TTM) · Derived
-1.1
P/S (TTM)
2.53
P/FCF (TTM) · Derived
-0.92
Rev YoY
-71.5%
EPS YoY
-49.1%
Gross Margin
+46.3%
Op Margin
-179.1%
Net Debt
-$219.79M
Current Ratio
5.25
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology